Guan, Xin, Luying Wang, Yang Cao, Fenghao Shi, He Xu, Jie Ding, Meiyu Wu, and Hongchao Li. 2023. “A Erratum on Cost Effectiveness Analysis of Blonanserin Versus Ziprasidone As First-Line Treatment for Patients With Schizophrenia in China”. Health Decision 1 (November). https://doi.org/10.54844/hd.2023.0498.